We are live on ! Find out more
HUMA icon

Humacyte
HUMA

123 hedge funds and large institutions have $150M invested in Humacyte in 2024 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 51 increasing their positions, 14 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

264% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 14

171% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 17

107% more capital invested

Capital invested by funds: $72.4M → $150M (+$77.4M)

28% more funds holding

Funds holding: 96 → 123 (+27)

6.3% more ownership

Funds ownership: 19.91% → 26.2% (+6.3%)

8% less call options, than puts

Call options by funds: $3.34M | Put options by funds: $3.61M

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
123
Holders Change
+27
Holders Change %
+28.13%
% of All Funds
1.78%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
46
Increased
51
Reduced
14
Closed
17
Calls
$3.34M
Puts
$3.61M
Net Calls
-$272K
Net Calls Change
+$483K

Top Buyers

1
BlackRock
BlackRock
New York
+$12.2M
2
State Street
State Street
Massachusetts
+$8.62M
3
Millennium Management
Millennium Management
New York
+$6.95M
4
N
Nuveen
North Carolina
+$6.05M
5
Two Sigma Investments
Two Sigma Investments
New York
+$5.81M

Top Sellers

1
ACM
AIGH Capital Management
Maryland
-$6.71M
2
SCM
Sio Capital Management
New York
-$6.22M
3
MIM
Monashee Investment Management
Massachusetts
-$3.75M
4
PGP
Prescott General Partners
Florida
-$1.77M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.09M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
51
Wells Fargo
California
$174K +$52.2K +10,027 +38%
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$173K +$112K +21,435 +146%
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$168K +$44.5K +8,557 +32%
Mirae Asset Global ETFs Holdings
54
Mirae Asset Global ETFs Holdings
Hong Kong
$167K +$181K +34,840 New
Group One Trading
55
Group One Trading
Illinois
$160K +$139K +26,627 +401%
Citigroup
56
Citigroup
New York
$151K +$108K +20,690 +193%
VOYA Investment Management
57
VOYA Investment Management
Georgia
$142K +$49.9K +9,582 +48%
Commonwealth Equity Services
58
Commonwealth Equity Services
Massachusetts
$140K -$66.3K -12,743 -30%
T. Rowe Price Associates
59
T. Rowe Price Associates
Maryland
$135K +$63.6K +12,216 +77%
TRCT
60
Tower Research Capital (TRC)
New York
$134K +$116K +22,217 +390%
AGM
61
Alpine Global Management
New York
$128K +$139K +26,744 New
Invesco
62
Invesco
Georgia
$126K +$22.4K +4,301 +20%
DTL
63
Dynamic Technology Lab
Singapore
$119K +$129K +24,734 New
XT
64
XTX Topco
Cayman Islands
$110K +$119K +22,877 New
DJYG
65
David J. Yvars Group
Florida
$109K +$118K +22,750 New
HLA
66
Hamilton Lane Advisors
Pennsylvania
$105K – – –
Deutsche Bank
67
Deutsche Bank
Germany
$99.3K -$39.8K -7,650 -27%
PA
68
Profund Advisors
Maryland
$97.3K +$106K +20,271 New
OAC
69
OMERS Administration Corp
Ontario, Canada
$94.1K +$102K +19,600 New
BHCM
70
Brevan Howard Capital Management
Jersey
$90.7K +$98.3K +18,890 New
Principal Financial Group
71
Principal Financial Group
Iowa
$82.5K +$89.5K +17,196 New
Verition Fund Management
72
Verition Fund Management
Connecticut
$77.5K +$84K +16,139 New
Cetera Investment Advisers
73
Cetera Investment Advisers
Illinois
$75.4K +$28.3K +5,446 +53%
ProShare Advisors
74
ProShare Advisors
Maryland
$74.7K -$14.1K -2,708 -15%
BCA
75
Bay Colony Advisors
Massachusetts
$69.8K -$41.1K -7,900 -35%
1 2
3
4 5

HUMA Hedge Fund Activity: Q2 2024 in Review

123 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q2 2024, worth a combined $150M — up 107% from $72.4M a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new HUMA positions and 17 closed out — a net gain of 29 holders — while 51 added to existing stakes and 14 trimmed.

The largest buyer was BlackRock, adding an estimated $12.2M. The largest seller was AIGH Capital Management, exiting entirely with an estimated $6.71M sold.

  • 123 institutional investors held Humacyte (HUMA) as of Q2 2024, up from 96 in Q1 2024.
  • Funds reported $150M of Humacyte stock for Q2 2024, up 107% quarter-over-quarter.
  • 46 funds opened new Humacyte positions in Q2 2024 and 17 closed out, a net change of +29 holders.
  • The largest Humacyte buyer in Q2 2024 was BlackRock, an estimated $12.2M added.
  • The largest Humacyte seller in Q2 2024 was AIGH Capital Management, an estimated $6.71M sold.

Based on aggregated 13F filings for Q2 2024.